11th Circ. Asked To Rehear Amgen, Pfizer Win In Enbrel Suit

By John Kennedy · February 13, 2018, 9:18 PM EST

The Eleventh Circuit failed to consider several issues when it ruled in favor of Amgen Inc., Pfizer Inc. and Wyeth Inc. in a lawsuit brought by a woman claiming their arthritis...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Rehearing Motion

Case Information

Case Title

Rebecca Small, et al v. AMGN, et al

Case Number

Court

Appellate - 11th Circuit

Nature of Suit

4365 Personal Injury-Product Liability

Date Filed

April 03, 2017

Recent Articles By John

March 06, 2019
Ky. Hospital Sues Travelers For $10M Over Shoddy Building
July 03, 2018
NY Panel Revives NYU Sandy Damage Claims Against Turner
March 01, 2018
HHS Must Reconsider Formula For ACA Payments
February 07, 2018
Epic Beats Whistleblower's 'Woefully Deficient' FCA Suit
February 06, 2018
UPenn Hospital Can't Yet Exit Brain-Damage Suit, Judge Says
February 06, 2018
Docs Call Cigna's 11th Circ. Appeal Over $25M Deal Premature
February 05, 2018
Ex-Doc Gets 8 Years For Fraud, Illegally Dispensing Opioids
February 05, 2018
Navajo Nation Sues HHS Over $7.2M Education Program Cut
February 02, 2018
2nd Circ. Affirms Dismissal Of Dr. Scholl's Class Action
February 01, 2018
Gov't Defends FCA Whistleblower Provision At 10th Circ.